Patent · US Active

Reduction of interferences in immunoassays

US12411129B2 · kind B2 · utility

0Cited by

2References

9Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Johannes Polz · Ziegelberg, DE
Thomas Mock · Canton, US
Barbara Upmeier · Iffeldorf, DE
Toralf Zarnt · Penzberg, DE

Key dates

Filing date	Sep 8, 2020
Grant date	Sep 9, 2025
Priority date	—
Expiry date	Sep 8, 2043

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/532
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a method for determining an analyte in a sample, comprising a) contacting said sample with at least a first and a second detector compound; b) determining the amount of complexes comprising at least one detector compound; and, c) determining said analyte in a sample based on the result of step b), wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical. The present invention further relates to a kit for detecting an analyte in a sample, comprising at least a first and a second detector compound for said analyte, wherein said first detector compound comprises a first binding moiety and a first label, and said second detector compound comprises a second binding moiety and a second label, and wherein the first label and the second label are non-identical; and to a device for determining an analyte in a sample, comprising at least a first and a second detector compound for said analyte, wherein said first detector compound comprises a first binding moiety and a first l…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.